1981 related articles for article (PubMed ID: 8223458)
1. Combinatorial generation of variable fusion proteins in the Ewing family of tumours.
Zucman J; Melot T; Desmaze C; Ghysdael J; Plougastel B; Peter M; Zucker JM; Triche TJ; Sheer D; Turc-Carel C
EMBO J; 1993 Dec; 12(12):4481-7. PubMed ID: 8223458
[TBL] [Abstract][Full Text] [Related]
2. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT
Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068
[TBL] [Abstract][Full Text] [Related]
3. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.
Bailly RA; Bosselut R; Zucman J; Cormier F; Delattre O; Roussel M; Thomas G; Ghysdael J
Mol Cell Biol; 1994 May; 14(5):3230-41. PubMed ID: 8164678
[TBL] [Abstract][Full Text] [Related]
4. Promiscuous partnerships in Ewing's sarcoma.
Sankar S; Lessnick SL
Cancer Genet; 2011 Jul; 204(7):351-65. PubMed ID: 21872822
[TBL] [Abstract][Full Text] [Related]
5. Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors.
Desmaze C; Brizard F; Turc-Carel C; Melot T; Delattre O; Thomas G; Aurias A
Cancer Genet Cytogenet; 1997 Aug; 97(1):12-9. PubMed ID: 9242212
[TBL] [Abstract][Full Text] [Related]
6. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
Kinsey M; Smith R; Lessnick SL
Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
[TBL] [Abstract][Full Text] [Related]
7. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.
May WA; Lessnick SL; Braun BS; Klemsz M; Lewis BC; Lunsford LB; Hromas R; Denny CT
Mol Cell Biol; 1993 Dec; 13(12):7393-8. PubMed ID: 8246959
[TBL] [Abstract][Full Text] [Related]
8. [The EWS gene rearrangement in Ewing tumors: key to the disease].
Kovar H; Zoubek A; Pfleiderer C; Jug G; Auinger A; Aryee D; Ambros PF; Salzer-Kuntschik M; Amann G; Windhager R
Klin Padiatr; 1994; 206(4):196-200. PubMed ID: 7967416
[TBL] [Abstract][Full Text] [Related]
9. EWS-FLI-1 and EWS-ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor.
Ida K; Kobayashi S; Taki T; Hanada R; Bessho F; Yamamori S; Sugimoto T; Ohki M; Hayashi Y
Int J Cancer; 1995 Nov; 63(4):500-4. PubMed ID: 7591257
[TBL] [Abstract][Full Text] [Related]
10. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations.
Giovannini M; Biegel JA; Serra M; Wang JY; Wei YH; Nycum L; Emanuel BS; Evans GA
J Clin Invest; 1994 Aug; 94(2):489-96. PubMed ID: 8040301
[TBL] [Abstract][Full Text] [Related]
11. SRE elements are binding sites for the fusion protein EWS-FLI-1.
Magnaghi-Jaulin L; Masutani H; Robin P; Lipinski M; Harel-Bellan A
Nucleic Acids Res; 1996 Mar; 24(6):1052-8. PubMed ID: 8604338
[TBL] [Abstract][Full Text] [Related]
12. Microsatellites as EWS/FLI response elements in Ewing's sarcoma.
Gangwal K; Sankar S; Hollenhorst PC; Kinsey M; Haroldsen SC; Shah AA; Boucher KM; Watkins WS; Jorde LB; Graves BJ; Lessnick SL
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10149-54. PubMed ID: 18626011
[TBL] [Abstract][Full Text] [Related]
13. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.
Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C
Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139
[TBL] [Abstract][Full Text] [Related]
14. EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.
Kinsey M; Smith R; Iyer AK; McCabe ER; Lessnick SL
Cancer Res; 2009 Dec; 69(23):9047-55. PubMed ID: 19920188
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of Ewing tumors: improved detection of EWS-FLI-1 and EWS-ERG chimeric transcripts and rapid determination of exon combinations.
Meier VS; Kühne T; Jundt G; Gudat F
Diagn Mol Pathol; 1998 Feb; 7(1):29-35. PubMed ID: 9646032
[TBL] [Abstract][Full Text] [Related]
16. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
[TBL] [Abstract][Full Text] [Related]
17. An EWS/ERG fusion with a truncated N-terminal domain of EWS in a Ewing's tumor.
Peter M; Mugneret F; Aurias A; Thomas G; Magdelenat H; Delattre O
Int J Cancer; 1996 Jul; 67(3):339-42. PubMed ID: 8707406
[TBL] [Abstract][Full Text] [Related]
18. [Ewing's tumours, genetic and cellular aspects].
Delattre O
Pathol Biol (Paris); 2008 Jul; 56(5):257-9. PubMed ID: 18485618
[TBL] [Abstract][Full Text] [Related]
19. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
[TBL] [Abstract][Full Text] [Related]
20. A new member of the ETS family fused to EWS in Ewing tumors.
Peter M; Couturier J; Pacquement H; Michon J; Thomas G; Magdelenat H; Delattre O
Oncogene; 1997 Mar; 14(10):1159-64. PubMed ID: 9121764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
